12.20 (0.75%) Sun Pharmaceutical Industries has no immediate plans to enter into vaccine production as getting into the vertical would require an altogether different manufacturing set-up. The Mumbai-based company, which is strong in various generic therapeutic segments, is eyeing biosimilars to fuel its future growth.
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.